Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Diflunisal in familial transthyretin amyloidosis
2011-000776-34Phase 4Completed
- Sponsor
- Umeå University
- Start
- May 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of diflunisal in hereditary transthyretin amyloidosis (hATTR), sponsored by Umeå University. Primary endpoint: Changes in the Kumamoto scale. Started May 2011; status: completed.
02
Drugs
diflunisal
03
Conditions
hereditary transthyretin amyloidosis (hATTR)
Beyond the preview
Go deeper on 2011-000776-34.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2011-000776-34.